Biological Therapy Analysis & Statistics, June 2014 (p6)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: Flow Cytometry, Hematology, Stem Cell, more »

151-180 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Induced Pluripotent Stem Cells : Global Markets

Induced Pluripotent Stem Cells : Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research report provides detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends of the field ...

  • Industries : Biological Therapy
  • Countries : World, United States
Stem Cell Research Market in India 2014

Stem Cell Research Market in India 2014

  • $ 950
  • Industry report
  • June 2014
  • by Netscribes (India) Pvt. Ltd.

Netscribes' latest market research report titled Stem Cell Research Market in India 2014 analyses how stem cell therapy is gaining importance in India as consumers realize the various benefits it offers. ...

  • Industries : Biological Therapy
  • Countries : India
BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review

BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • June 2014
  • by Global Data

BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biological Therapy
  • Countries : United States
Physician Views: Are neurologists ready to embrace gene therapy?

Physician Views: Are neurologists ready to embrace gene therapy?

  • $ 645
  • Industry report
  • June 2014
  • by Firstword Pharma

Description As recently noted by Forbes, the biotech bull market of 2013 has helped to revive an approach to drug development that had become largely abandoned and pursued by only a few devoted believers. ...

  • Industries : Biological Therapy
  • Countries : United States
Herceptin-Drug Insights,2014

Herceptin-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Herceptin - Drug Insights, 2014” provides Herceptin marketed details and API Manufacturers details across the globe along with the location. In addition, it ...

  • Industries : Biological Therapy
  • Countries : United States
Procrit-Drug Insights,2014

Procrit-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Procrit - Drug Insights, 2014” provides Procrit marketed details and API Manufacturers details across the globe along with the location. In addition, it covers ...

  • Industries : Biological Therapy
  • Countries : United States
Rituxan-Drug Insights,2014

Rituxan-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Rituxan - Drug Insights, 2014” provides Rituxan marketed details and API Manufacturers details across the globe along with the location. In addition, it covers ...

  • Industries : Biological Therapy
  • Countries : United States
Neupogen-Drug Insights,2014

Neupogen-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Neupogen - Drug Insights, 2014” provides Neupogen marketed details and API Manufacturers details across the globe along with the location. In addition, it covers ...

  • Industries : Biological Therapy
  • Countries : United States
The Future of Cancer Immunotherapy: KOL Views Bring Opportunities into Sharp Focus

The Future of Cancer Immunotherapy: KOL Views Bring Opportunities into Sharp Focus

  • $ 4 995
  • Industry report
  • June 2014
  • by Firstword Pharma

There has been considerable media hype and clinical interest in cancer immunotherapy in recent years. Indeed, there is talk of late stage cancers such as melanoma and NSCLC being managed as chronic conditions ...

  • Industries : Biological Therapy
Stem Cell Research Products: Opportunities, Tools & Technologies

Stem Cell Research Products: Opportunities, Tools & Technologies

  • $ 3 495
  • Industry report
  • June 2014
  • by BioInformant Worldwide, L.L.C.

EXECUTIVE SUMMARY Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Stem cells are ...

  • Industries : Biological Therapy
  • Countries : United States
Medicyte GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Medicyte GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary MediCyte GmbH (MediCyte) is a life science company. The company carries out controlled, scalable propagation and standardization of human primary cell products. It provides solutions in the areas ...

  • Industries : Biological Therapy
Harvard Bioscience, Inc. (HBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Harvard Bioscience, Inc. (HBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Harvard Bioscience, Inc. (Harvard Bioscience) is a developer, manufacturer and marketer of scientific instruments, systems, and lab consumables for life science research, drug discovery, and clinical ...

  • Industries : Biological Therapy
Stemgent, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stemgent, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Stemgent, Inc. (Stemgent) is a biotechnology company. It focuses on the development of innovative technology and application solutions for the advancement of stem cell research. The company's product ...

  • Industries : Biological Therapy
  • Countries : United States
Cell Separation Technologies Market (Technology: Gradient Centrifugation, MACS and FACS; Application: Stem Cell Research, Immunology, Neuroscience and Cancer Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Cell Separation Technologies Market (Technology: Gradient Centrifugation, MACS and FACS; Application: Stem Cell Research, Immunology, Neuroscience and Cancer Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • May 2014
  • by Transparency Market Research

This report consists of the market analysis for the various technologies used in the cell separation market. Increasing cell therapy oriented research and development globally is driving the cell separation ...

  • Industries : Biological Therapy
  • Countries : World
Advanced Cell Technology, Inc. (ACTC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Advanced Cell Technology, Inc. (ACTC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Advanced Cell Technology, Inc. (ACT) is a biotechnology company, specializes in regenerative medicine. The company participates in the development of cellular therapies for the treatment of diseases. ...

  • Industries : Biological Therapy
  • Countries : United States, World
Bioheart, Inc. (BHRT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioheart, Inc. (BHRT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Bioheart, Inc. (Bioheart) is a biotechnology company. It focuses solely on providing cell technologies that aid in the treatment of cardiovascular and related diseases. Its product candidates ...

  • Industries : Biological Therapy
  • Countries : United States
Cytomedix, Inc. (CMXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cytomedix, Inc. (CMXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Cytomedix, Inc. (Cytomedix) is an integrated regenerative medicine company that develops and commercializes innovative platelet and adult stem cell separation products that boosts the body's natural ...

  • Industries : Biological Therapy
  • Countries : United States
BioTime, Inc. (BTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioTime, Inc. (BTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary BioTime, Inc. (BioTime) is a biotechnology company. It is focused on research and development in the field of regenerative medicine. The company's products can be used in various fields of medicine ...

  • Industries : Biological Therapy
  • Countries : United States
Promethera Biosciences S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Promethera Biosciences S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary PROMETHERA Biosciences S.A. (Promethera) is a pharmaceutical company. The company designs, develops and commercializes cell therapy products for the treatment of liver diseases. It develops innovative ...

  • Industries : Biological Therapy
The Hospital for Sick Children - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Hospital for Sick Children - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary The Hospital for Sick Children (SickKids) is a healthcare service provider. The hospital offers children's health, research and education services. Its services include accommodations, chaplains, ...

  • Industries : Biological Therapy
  • Countries : Canada
K-Stemcell Co., Ltd. (003190) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

K-Stemcell Co., Ltd. (003190) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary K-Stemcell Co., Ltd. (K-Stemcell) formerly RNL BIO Co., Ltd. is a biotechnology company, based in Republic of Korea. The company develops, manufactures and markets stem cell therapy products. It ...

  • Industries : Biological Therapy
  • Countries : South Korea
Lonza Group Ltd (LONN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Lonza Group Ltd (LONN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Lonza Group Ltd (Lonza) is a pharmaceutical company. It manufactures and develops chemical and biological active pharmaceutical ingredients, and other products and services. The company's services ...

  • Industries : Biological Therapy
  • Countries : United States, Singapore
Northwest Biotherapeutics, Inc. (Symbol:NWBO) SWOT Analysis, Strategy, Revenues and Profits

Northwest Biotherapeutics, Inc. (Symbol:NWBO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
Fluxion Biosciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Fluxion Biosciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Fluxion Biosciences, Inc. (Fluxion) is a biotechnology company. The company provides analytical, live cell analysis tools to facilitate research discoveries and diagnostics. Its products include ...

  • Industries : Biological Therapy
Aldagen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aldagen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Aldagen, Inc. (Aldagen) is a bio-pharmaceutical company based in the US. The company develops proprietary adult stem cell products for tissue repair and regeneration. It provides clinical development ...

  • Industries : Biological Therapy
  • Countries : United States
EMD Millipore Corporation - Strategic SWOT Analysis Review

EMD Millipore Corporation - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2014
  • by Global Data

EMD Millipore Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed ...

  • Industries : Biological Therapy
  • Countries : United States
Bioheart, Inc. (BHRT) - Product Pipeline Analysis, 2014 Update

Bioheart, Inc. (BHRT) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • May 2014
  • by Global Data

Summary Bioheart, Inc. (Bioheart) is a biotechnology company. It focuses solely on providing cell technologies that aid in the treatment of cardiovascular and related diseases. Its product candidates ...

  • Industries : Biological Therapy
  • Countries : United States
ReNeuron Group plc (RENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ReNeuron Group plc (RENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary ReNeuron Group plc (ReNeuron) is a clinical-stage stem cell company. It carries out the research, development, and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic ...

  • Industries : Biological Therapy
Benitec Biopharma Limited (BLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Benitec Biopharma Limited (BLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Benitec Biopharma Limited (Benitec), formerly Benitec Limited, is a research focused biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening ...

  • Industries : Biological Therapy
  • Countries : Australia
CHA Bio & Diostech Co., Ltd. (085660) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CHA Bio & Diostech Co., Ltd. (085660) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary CHA Bio & Diostech Co., Ltd. (CHA Bio & Diostech) is a bio technology company, based in South Korea. It develops advance biomedicine through applied life science and technology. The company's products ...

  • Industries : Biological Therapy
  • Countries : South Korea

33 Companies

Read our Company Profiles

Bioheart Inc.

United States

StemCells Inc.

United States

Aastrom Biosciences Inc.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.